Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Obamacare’s Brand Drug Tax Would Be Repealed Under GOP’s ‘Replace’ Proposal

This article was originally published in The Pink Sheet Daily

Executive Summary

Industry hasn’t publicly opposed the tax, which it negotiated as part of the creation of the Affordable Care Act.

You may also be interested in...

Is This The Year R&D Tax Credits Become Permanent?

Senate Finance Committee Chairman Hatch’s top priority for the year is to develop legislation reforming the tax code. He forms five bipartisan committee working groups to develop and submit legislative recommendations by May.

$8 Billion And Counting: Pharma Paying Its ACA Taxes

HHS OIG report shows pharma industry fee is being paid, albeit with a few bumps along the way.

GSK's Nucala Is Significantly Overpriced, ICER Draft Report Finds

New biologic for severe asthma doesn't stack up well to standard of care on generally accepted levels of cost per quality-adjusted life year.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts